Abstract

Nucleic acid polymer complexes represent a significant advancement in the treatment of neurological disorders by enabling precision medication delivery. These complexes combine nucleic acids with synthetic or natural polymers to enhance the stability, targeting, and efficacy of therapeutic agents. This innovative approach addresses the limitations of traditional drug delivery systems, providing targeted and sustained release directly to affected neurological tissues. Applications in gene therapy, targeted drug delivery for protein accumulation diseases, and anti-inflammatory treatments highlight their potential to revolutionize therapy for conditions such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. Ongoing research and development promise further improvements, making nucleic acid polymer complexes a transformative tool in personalized neurological disorder management.